scholarly article | Q13442814 |
P2093 | author name string | H Liu | |
T O Daniel | |||
A Walz | |||
M D Burdick | |||
R M Strieter | |||
A Richmond | |||
C L Addison | |||
J E Ehlert | |||
L Buechi | |||
Y Y Xue | |||
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 5269-5277 | |
P577 | publication date | 2000-11-01 | |
P1433 | published in | Journal of Immunology | Q3521441 |
P1476 | title | The CXC chemokine receptor 2, CXCR2, is the putative receptor for ELR+ CXC chemokine-induced angiogenic activity | |
P478 | volume | 165 |
Q40561912 | A phase I trial of immunotherapy with intratumoral adenovirus-interferon-gamma (TG1041) in patients with malignant melanoma. |
Q28566820 | A role for a CXCR2/phosphatidylinositol 3-kinase gamma signaling axis in acute and chronic vascular permeability. |
Q46753836 | Acidic pH stimulates the production of the angiogenic CXC chemokine, CXCL8 (interleukin-8), in human adult mesenchymal stem cells via the extracellular signal-regulated kinase, p38 mitogen-activated protein kinase, and NF-kappaB pathways |
Q37665083 | Adaptor protein2 (AP2) orchestrates CXCR2-mediated cell migration |
Q34345236 | An IP-10 (CXCL10)-derived peptide inhibits angiogenesis |
Q36616466 | An important role of blood and lymphatic vessels in inflammation and allergy |
Q25257892 | Analysis of the human cytomegalovirus genomic region from UL146 through UL147A reveals sequence hypervariability, genotypic stability, and overlapping transcripts |
Q35048828 | Analysis of the role of chemokines in angiogenesis. |
Q34989354 | Angiogenesis and chemokines in rheumatoid arthritis and other systemic inflammatory rheumatic diseases. |
Q57050421 | Angiogenic Properties of 'Leukocyte- and Platelet-Rich Fibrin' |
Q58905775 | Anti-angiogenesis and angioprevention: mechanisms, problems and perspectives |
Q35753903 | Association between preeclampsia and the CXC chemokine family (Review). |
Q38909630 | Autocrine control of MIP-2 secretion from metastatic breast cancer cells is mediated by CXCR2: a mechanism for possible resistance to CXCR2 antagonists |
Q40379705 | Autocrine role of interleukin-8 in induction of endothelial cell proliferation, survival, migration and MMP-2 production and angiogenesis |
Q36590676 | Bioimmunotherapy for melanoma using fully human antibodies targeting MCAM/MUC18 and IL-8. |
Q64095664 | Bladder cancer cells interact with vascular endothelial cells triggering EGFR signals to promote tumor progression |
Q40462497 | Breast tumor cell soluble factors induce monocytes to produce angiogenic but not angiostatic CXC chemokines. |
Q46816224 | CXC chemokine KC fails to induce neutrophil infiltration and neoangiogenesis in a mouse model of myocardial infarction |
Q36616524 | CXC chemokines and prostate cancer: growth regulators and potential biomarkers |
Q35165427 | CXC chemokines function as a rheostat for hepatocyte proliferation and liver regeneration |
Q30432791 | CXC chemokines in cancer angiogenesis and metastases |
Q39853277 | CXC-chemokine/CXCR2 biological axis promotes angiogenesis in vitro and in vivo in pancreatic cancer |
Q28253682 | CXCL1 promotes arteriogenesis through enhanced monocyte recruitment into the peri-collateral space |
Q38052061 | CXCL10 activities, biological structure, and source along with its significant role played in pathophysiology of type I diabetes mellitus. |
Q64118296 | CXCL5 induces tumor angiogenesis via enhancing the expression of FOXD1 mediated by the AKT/NF-κB pathway in colorectal cancer |
Q33708424 | CXCL5 is required for angiogenesis, but not structural adaptation after small bowel resection |
Q37658774 | CXCL8 and its cognate receptors in melanoma progression and metastasis |
Q37228501 | CXCR1 and CXCR2 enhances human melanoma tumourigenesis, growth and invasion |
Q35549511 | CXCR1 and CXCR2 silencing modulates CXCL8-dependent endothelial cell proliferation, migration and capillary-like structure formation |
Q35790380 | CXCR2 Inhibition Combined with Sorafenib Improved Antitumor and Antiangiogenic Response in Preclinical Models of Ovarian Cancer |
Q34208664 | CXCR2 agonists in ADPKD liver cyst fluids promote cell proliferation. |
Q37341761 | CXCR2 and RET single nucleotide polymorphisms in pancreatic cancer |
Q92509196 | CXCR2 expression on granulocyte and macrophage progenitors under tumor conditions contributes to mo-MDSC generation via SAP18/ERK/STAT3 |
Q58761517 | CXCR2 is a novel cancer stem-like cell marker for triple-negative breast cancer |
Q35626859 | CXCR2 is essential for cerebral endothelial activation and leukocyte recruitment during neuroinflammation |
Q36064553 | CXCR2 mediates the recruitment of endothelial progenitor cells during allergic airways remodeling. |
Q38039412 | CXCR2: From Bench to Bedside |
Q27021588 | CXCR2: a target for pancreatic cancer treatment? |
Q30408881 | CXCR4, but not CXCR7, discriminates metastatic behavior in non-small cell lung cancer cells |
Q24292394 | Ca(2+) signalling by recombinant human CXCR2 chemokine receptors is potentiated by P2Y nucleotide receptors in HEK cells |
Q93261627 | Cancer cell-derived interleukin-33 decoy receptor sST2 enhances orthotopic tumor growth in a murine pancreatic cancer model |
Q90656757 | Cell-specific regulatory effects of CXCR2 on cholestatic liver injury |
Q39822442 | Characterization of contraction-inducible CXC chemokines and their roles in C2C12 myocytes. |
Q46299056 | Chemokine (C-X-C motif) ligand 1 is a myokine induced by palmitate and is required for myogenesis in mouse satellite cells |
Q34208227 | Chemokine CXCL1/KC and its receptor CXCR2 are responsible for neutrophil chemotaxis in adenoviral keratitis |
Q26778694 | Chemokine Regulation of Neutrophil Infiltration of Skin Wounds |
Q84156302 | Chemokine and chemokine receptor expression analysis in target organs of acute graft-versus-host disease |
Q49167055 | Chemokine ligand-receptor interactions critically regulate cutaneous wound healing |
Q37351199 | Chemokine receptor CXCR4 as a therapeutic target for neuroectodermal tumors |
Q35784424 | Chemokine receptors CXCR2 and CX3CR1 differentially regulate functional responses of bone-marrow endothelial progenitors during atherosclerotic plaque regression |
Q24803643 | Chemokine receptors in the rheumatoid synovium: upregulation of CXCR5 |
Q38040509 | Chemokine-based immunotherapy: delivery systems and combination therapies. |
Q60931267 | Chemokines and Chemokine Receptors: Orchestrating Tumor Metastasization |
Q42862270 | Chemokines and Their Receptors Are Key Players in the Orchestra That Regulates Wound Healing |
Q35031896 | Chemokines and chemokine receptors in rheumatoid arthritis |
Q27687402 | Chemokines and chemokine receptors: update on utility and challenges for the clinician |
Q30426904 | Chemokines as mediators of angiogenesis. |
Q30438032 | Chemokines as mediators of neovascularization |
Q30427886 | Chemokines as mediators of tumor angiogenesis and neovascularization |
Q26778684 | Chemokines in Wound Healing and as Potential Therapeutic Targets for Reducing Cutaneous Scarring |
Q83169012 | Chemokines in health and disease |
Q35553416 | Chemokines in joint disease: the key to inflammation? |
Q36780595 | Chemokines in the biology of lung cancer. |
Q34540743 | Chemokines in tumor angiogenesis and metastasis |
Q37950700 | Chemokines in tumor development and progression. |
Q34548307 | Chemokines--linking receptors to response. |
Q36687945 | Chemokines: inflammatory mediators of atherosclerosis |
Q36918688 | Chemokines: novel targets for breast cancer metastasis |
Q36262470 | Chemokines: their role in rheumatoid arthritis |
Q33602017 | Combined effects of IL-8 and CXCR2 gene polymorphisms on breast cancer susceptibility and aggressiveness |
Q37052856 | Concise review: immunological properties of ocular surface and importance of limbal stem cells for transplantation |
Q64083651 | Constitutive and LPS-stimulated secretome of porcine Vascular Wall-Mesenchymal Stem Cells exerts effects on in vitro endothelial angiogenesis |
Q40443266 | Constitutive expression of growth regulated oncogene (gro) in human colon carcinoma cells with different metastatic potential and its role in regulating their metastatic phenotype |
Q34404577 | Control of CXCR2 activity through its ubiquitination on K327 residue. |
Q35162409 | Controlled protein delivery in the generation of microvascular networks. |
Q39953292 | Cooperative regulation of non-small cell lung carcinoma angiogenic potential by macrophage migration inhibitory factor and its homolog, D-dopachrome tautomerase |
Q34816925 | Critical role for CXCR2 and CXCR2 ligands during the pathogenesis of ventilator-induced lung injury |
Q37400654 | Cyclic AMP-responsive element binding protein- and nuclear factor-kappaB-regulated CXC chemokine gene expression in lung carcinogenesis |
Q46118909 | Decidual stromal cell response to paracrine signals from the trophoblast: amplification of immune and angiogenic modulators |
Q24647498 | Delayed wound healing in CXCR2 knockout mice |
Q35963152 | Dexamethasone inhibits interleukin-1beta-induced corneal neovascularization: role of nuclear factor-kappaB-activated stromal cells in inflammatory angiogenesis |
Q45275725 | Difference in proangiogenic potential of systemic and pulmonary endothelium: role of CXCR2. |
Q24807287 | Differential binding of chemokines to macrophages and neutrophils in the human inflamed synovium |
Q39738425 | Differential expression of the chemokines GRO-2, GRO-3, and interleukin-8 in colon cancer and their impact on metastatic disease and survival |
Q41913259 | Differential roles of CXCL2 and CXCL3 and their receptors in regulating normal and asthmatic airway smooth muscle cell migration |
Q77931663 | Differentiated HL-60 cells are a valid model system for the analysis of human neutrophil migration and chemotaxis |
Q96816993 | EGFR/Ras-induced CCL20 production modulates the tumour microenvironment |
Q33346619 | ELR+ CXC chemokine expression in benign and malignant colorectal conditions |
Q35220405 | Early neutrophil recruitment and aggregation in the murine lung inhibit germination of Aspergillus fumigatus Conidia |
Q46213040 | Epidermal growth factor receptor reactivation induced by E-prostanoid-3 receptor- and tumor necrosis factor-alpha-converting enzyme-dependent feedback exaggerates interleukin-8 production in airway cancer (NCI-H292) cells |
Q33578550 | Epidermal growth factor receptor signaling modulates chemokine (CXC) ligand 5 expression and is associated with villus angiogenesis after small bowel resection |
Q28743229 | Epigenetics underpinning the regulation of the CXC (ELR+) chemokines in non-small cell lung cancer |
Q24529528 | Essential role for Galpha13 in endothelial cells during embryonic development |
Q34790159 | Evidence that cathelicidin peptide LL-37 may act as a functional ligand for CXCR2 on human neutrophils |
Q51382068 | Exercise-induced liver chemokine CXCL-1 expression is linked to muscle-derived interleukin-6 expression. |
Q33562569 | Expression of CXCL10 is associated with response to radiotherapy and overall survival in squamous cell carcinoma of the tongue |
Q47276398 | Expression of CXCR1 and CXCR2 receptors in malignant melanoma with different metastatic potential and their role in interleukin-8 (CXCL-8)-mediated modulation of metastatic phenotype |
Q34134989 | Expression of the duffy antigen/receptor for chemokines (DARC) by the inflamed synovial endothelium |
Q37452592 | Functional Genomics Identifies Tis21-Dependent Mechanisms and Putative Cancer Drug Targets Underlying Medulloblastoma Shh-Type Development. |
Q37149865 | Functional characterization of chimpanzee cytomegalovirus chemokine, vCXCL-1(CCMV) |
Q30413082 | G protein-coupled receptor kinase 6 deficiency promotes angiogenesis, tumor progression, and metastasis |
Q57584381 | GCP-2/CXCL6 synergizes with other endothelial cell-derived chemokines in neutrophil mobilization and is associated with angiogenesis in gastrointestinal tumors |
Q36221840 | HIV-1 matrix protein p17 promotes angiogenesis via chemokine receptors CXCR1 and CXCR2. |
Q43580944 | High expression of CXCR2 is associated with tumorigenesis, progression, and prognosis of laryngeal squamous cell carcinoma |
Q37120171 | Host CXCR2-dependent regulation of melanoma growth, angiogenesis, and experimental lung metastasis |
Q36767227 | Host Cxcr2-dependent regulation of mammary tumor growth and metastasis |
Q45119303 | Human neutrophils promote angiogenesis by a paracrine feedforward mechanism involving endothelial interleukin-8. |
Q37149868 | Hypoxia enhances CXCR4 expression in human microvascular endothelial cells and human melanoma cells |
Q39496836 | IL-8-mediated angiogenic responses of endothelial cells to lipid antigen activation of iNKT cells depend on EGFR transactivation |
Q92582058 | IL‑17A promotes CXCR2‑dependent angiogenesis in a mouse model of liver cancer |
Q35044351 | Identification of a functional SNP in the 3'UTR of CXCR2 that is associated with reduced risk of lung cancer |
Q54788103 | Identification of genes promoting angiogenesis in mouse lung by transcriptional profiling. |
Q33634642 | Immunohistochemical analysis of IL-6, IL-8/CXCR2 axis, Tyr p-STAT-3, and SOCS-3 in lymph nodes from patients with chronic lymphocytic leukemia: correlation between microvascular characteristics and prognostic significance. |
Q51714575 | Immunohistochemical distinction of metastases of renal cell carcinoma with molecular analysis of overexpression of the chemokines CXCR2 and CXCR3 as independent positive prognostic factors for the tumorigenesis. |
Q35048821 | In situ binding assay for studying chemokine interactions with endothelial cells |
Q34653700 | Inconformity of CXCL3 plasma level and placenta expression in preeclampsia and its effect on trophoblast viability and invasion |
Q46601343 | Increased expression of chemokine KC, an interleukin-8 homologue, in a model of oxygen-induced retinopathy |
Q36405907 | Induction of CXC chemokines in human mesenchymal stem cells by stimulation with secreted frizzled-related proteins through non-canonical Wnt signaling |
Q42036547 | Infiltration of COX-2-expressing macrophages is a prerequisite for IL-1 beta-induced neovascularization and tumor growth. |
Q38121413 | Inflammatory chemokines and metastasis--tracing the accessory |
Q46716190 | Inhibition of CXCR2 attenuates bronchial angiogenesis in the ischemic rat lung |
Q91584509 | Insights on CXC chemokine receptor 2 in breast cancer: An emerging target for oncotherapy |
Q42777861 | Interleukin 8 mediates bcl-xL-induced enhancement of human melanoma cell dissemination and angiogenesis in a zebrafish xenograft model. |
Q37070979 | Interleukin-19 induces angiogenesis in the absence of hypoxia by direct and indirect immune mechanisms |
Q34442262 | Interleukin-8 receptor antagonists in pulmonary diseases |
Q38799309 | Interleukin-8/CXCL8 is a growth factor for human lung cancer cells |
Q37432097 | International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors |
Q42818551 | KSHV-GPCR and CXCR2 transforming capacity and angiogenic responses are mediated through a JAK2-STAT3-dependent pathway |
Q37344018 | Keratinocyte-derived chemokine in obesity: expression, regulation, and role in adipose macrophage infiltration and glucose homeostasis |
Q30009171 | LASP-1: a nuclear hub for the UHRF1-DNMT1-G9a-Snail1 complex |
Q30156891 | LIM and SH3 protein-1 modulates CXCR2-mediated cell migration |
Q41721776 | Loss of β-arrestin-2 and Activation of CXCR2 Correlate with Lymph Node Metastasis in Non-small Cell Lung Cancer |
Q90665164 | Metastasis-associated fibroblasts promote angiogenesis in metastasized pancreatic cancer via the CXCL8 and the CCL2 axes |
Q36429600 | Mitogenic effects of interleukin-8/CXCL8 on cancer cells |
Q38774697 | Modulation of Neuroinflammation in the Central Nervous System: Role of Chemokines and Sphingolipids |
Q50423780 | Molecular Regulation of Sprouting Angiogenesis |
Q34360586 | Muscle as a secretory organ |
Q44491363 | Muscle-derived expression of the chemokine CXCL1 attenuates diet-induced obesity and improves fatty acid oxidation in the muscle |
Q34265667 | Muscles, exercise and obesity: skeletal muscle as a secretory organ |
Q34257883 | Myeloid derived hypoxia inducible factor 1-alpha is required for protection against pulmonary Aspergillus fumigatus infection |
Q33322533 | Nanofibrous scaffolds incorporating PDGF-BB microspheres induce chemokine expression and tissue neogenesis in vivo |
Q37684330 | Neutralizing endogenous chemokines with small molecules. Principles and potential therapeutic applications. |
Q38267059 | New insights into ADAMs regulation of the GRO-α/CXCR2 system: focus on Sjögren's syndrome |
Q28387389 | Nickel and the microbial toxin, MALP-2, stimulate proangiogenic mediators from human lung fibroblasts via a HIF-1alpha and COX-2-mediated pathway |
Q35671858 | Oncomodulatory signals by regulatory proteins encoded by human cytomegalovirus: a novel role for viral infection in tumor progression |
Q30439835 | Opposing roles of murine duffy antigen receptor for chemokine and murine CXC chemokine receptor-2 receptors in murine melanoma tumor growth |
Q30438282 | Out of the shadows: CXC chemokines in promoting aberrant lung cancer angiogenesis |
Q30427989 | Overexpression of CXCL5 is associated with poor survival in patients with pancreatic cancer |
Q35223880 | Overexpression of chemokine receptor CXCR2 and ligand CXCL7 in liver metastases from colon cancer is correlated to shorter disease-free and overall survival |
Q34768343 | PPAR-gamma activation inhibits angiogenesis by blocking ELR+CXC chemokine production in non-small cell lung cancer |
Q37115840 | Pathophysiological roles of microvascular alterations in pulmonary inflammatory diseases: possible implications of tumor necrosis factor-alpha and CXC chemokines |
Q35498810 | Phage display and hybridoma generation of antibodies to human CXCR2 yields antibodies with distinct mechanisms and epitopes |
Q38111715 | Physiological and pathological angiogenesis in the adult pulmonary circulation |
Q37705023 | Platelet-derived chemokines: pathophysiology and therapeutic aspects |
Q33949172 | Polycystic liver diseases. |
Q37480371 | Possible angiogenic roles for claudin-4 in ovarian cancer |
Q42047812 | Potential interaction between CCR1 and its ligand, CCL3, induced by endogenously produced interleukin-1 in human hepatomas |
Q36557140 | Primary tumor- and metastasis-derived colon cancer cells differently modulate connexin expression and function in human capillary endothelial cells |
Q37266333 | Prostaglandin F2alpha-F-prostanoid receptor signaling promotes neutrophil chemotaxis via chemokine (C-X-C motif) ligand 1 in endometrial adenocarcinoma |
Q26775965 | Recent advances in understanding the roles of vascular endothelial cells in allergic inflammation |
Q40726082 | Receptor binding mode and pharmacological characterization of a potent and selective dual CXCR1/CXCR2 non-competitive allosteric inhibitor. |
Q33581032 | Reduction of monocyte chemoattractant protein-1 and interleukin-8 levels by ticlopidine in TNF-alpha stimulated human umbilical vein endothelial cells |
Q36472048 | Regulation of fibrosis by the immune system |
Q28237665 | Regulation of the immune response by the interaction of chemokines and proteases |
Q42727110 | Role of CXCR2/CXCR2 ligands in vascular remodeling during bronchiolitis obliterans syndrome |
Q36120825 | Role of chemokines in tumor growth |
Q37833076 | Role of endothelial chemokines and their receptors during inflammation |
Q30393808 | Role of leukotriene A4 hydrolase aminopeptidase in the pathogenesis of emphysema |
Q30438786 | Role of neutrophils in response to Bordetella pertussis infection in mice |
Q39321350 | Role of the CXCL8-CXCR1/2 Axis in Cancer and Inflammatory Diseases |
Q37959540 | Roles of IL-8 in ocular inflammations: a review. |
Q85076018 | Roles of mechanical force and CXCR1/CXCR2 in shear-stress-induced endothelial cell migration |
Q30439068 | Short tail with skin lesion phenotype occurs in transgenic mice with keratin-14 promoter-directed expression of mutant CXCR2. |
Q34367591 | Small molecule antagonists for CXCR2 and CXCR1 inhibit human colon cancer liver metastases |
Q34512415 | Small-molecule antagonists for CXCR2 and CXCR1 inhibit human melanoma growth by decreasing tumor cell proliferation, survival, and angiogenesis |
Q33500805 | Spatiotemporal expression of chemokines and chemokine receptors in experimental anti-myeloperoxidase antibody-mediated glomerulonephritis |
Q27680153 | Structural Insights into Neutrophilic Migration Revealed by the Crystal Structure of the Chemokine Receptor CXCR2 in Complex with the First PDZ Domain of NHERF1 |
Q51145586 | Structural basis of PDZ-mediated chemokine receptor CXCR2 scaffolding by guanine nucleotide exchange factor PDZ-RhoGEF. |
Q64244049 | Support of Tumor Endothelial Cells by Chemokine Receptors |
Q44747049 | Surgical stimulation of angiogenesis |
Q46442602 | Synthesis, ADMET Properties, and Biological Evaluation of Benzothiazole Compounds Targeting Chemokine Receptor 2 (CXCR2). |
Q49406198 | Systematic review and meta-analysis of the prognostic value of CXCR2 in solid tumor patients |
Q56242174 | THIS ARTICLE HAS BEEN RETRACTED Exercise induces interleukin-8 expression in human skeletal muscle |
Q37370810 | TNF-α augments CXCR2 and CXCR3 to promote progression of renal cell carcinoma |
Q28276026 | Targeting CXCR1/CXCR2 receptor antagonism in malignant melanoma |
Q36843035 | Targeting CXCR2 enhances chemotherapeutic response, inhibits mammary tumor growth, angiogenesis, and lung metastasis. |
Q36187424 | Targeting chemokine pathways in esophageal adenocarcinoma |
Q57273079 | Th1/Th2 Cytokines Reciprocally RegulateIn VitroPulmonary Angiogenesis via CXC Chemokine Synthesis |
Q44273260 | The CXC chemokine GCP-2/CXCL6 is predominantly induced in mesenchymal cells by interleukin-1beta and is down-regulated by interferon-gamma: comparison with interleukin-8/CXCL8. |
Q24603045 | The Duffy Antigen/Receptor for Chemokines (DARC) and prostate-cancer risk among Jamaican men |
Q39825301 | The G protein-coupled receptor 87 is necessary for p53-dependent cell survival in response to genotoxic stress |
Q33592512 | The Ron receptor tyrosine kinase positively regulates angiogenic chemokine production in prostate cancer cells |
Q28579543 | The angiogenic response of the aorta to injury and inflammatory cytokines requires macrophages |
Q24606039 | The chemokine CCL18 causes maturation of cultured monocytes to macrophages in the M2 spectrum |
Q36837870 | The chemokine system in arteriogenesis and hind limb ischemia |
Q54691788 | The contribution of chemokines and chemokine receptors to the rejection of fetal proislet allografts. |
Q39616316 | The cytomegalovirus UL146 gene product vCXCL1 targets both CXCR1 and CXCR2 as an agonist |
Q35629760 | The effect of impaired angiogenesis on intestinal function following massive small bowel resection |
Q37020092 | The epidermal growth factor receptor system in skin repair and inflammation |
Q80532314 | The epithelial-mesenchymal transition of colon carcinoma involves expression of IL-8 and CXCR-1-mediated chemotaxis |
Q35231687 | The functional role of reactive stroma in benign prostatic hyperplasia |
Q89636461 | The health status alters the pituitary function and reproduction of mice in a Cxcr2-dependent manner |
Q35895796 | The matrikine N-α-PGP couples extracellular matrix fragmentation to endothelial permeability |
Q34790019 | The molecular control of angiogenesis |
Q35819575 | The prognostic value of CXC-chemokine receptor 2 (CXCR2) in gastric cancer patients |
Q33294346 | The proinflammatory CXC-chemokines GRO-alpha/CXCL1 and MIG/CXCL9 are concomitantly expressed in ulcerative colitis and decrease during treatment with topical corticosteroids |
Q38023245 | The role of CXC chemokines and their receptors in the progression and treatment of tumors |
Q30443091 | The role of CXC chemokines in pulmonary fibrosis |
Q33589279 | The role of CXC-chemokine receptor CXCR2 and suppressor of cytokine signaling-3 (SOCS-3) in renal cell carcinoma |
Q37863514 | The role of chemokines and their receptors in angiogenesis |
Q37989141 | The role of chemokines in mediating graft versus host disease: opportunities for novel therapeutics. |
Q36360715 | The role of chemokines in rheumatoid arthritis and osteoarthritis |
Q34411509 | The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis |
Q90447370 | The significance of chemokine CXCL-8 in esophageal carcinoma |
Q36956642 | The small tellurium-based compound SAS suppresses inflammation in human retinal pigment epithelium |
Q54609303 | Topical steroids do not downregulate expression of growth-related oncogene-alpha in nasal polyps. |
Q36173954 | Transactivation of vascular endothelial growth factor receptor-2 by interleukin-8 (IL-8/CXCL8) is required for IL-8/CXCL8-induced endothelial permeability |
Q40486064 | Transient inflammatory response induced by apoptotic cells is an important mediator of melanoma cell engraftment and growth |
Q35838937 | Trefoil Factor-3 (TFF3) Stimulates De Novo Angiogenesis in Mammary Carcinoma both Directly and Indirectly via IL-8/CXCR2. |
Q42109061 | Tumor Necrosis Factor (TNF) and Chemokines in Colitis-Associated Cancer |
Q34272896 | Tumor necrosis factor-related apoptosis-inducing ligand induces caspase-dependent interleukin-8 expression and apoptosis in human astroglioma cells |
Q34105482 | Tumorigenesis induced by the HHV8-encoded chemokine receptor requires ligand modulation of high constitutive activity. |
Q39628714 | Twin Attributes of Tyrosyl-tRNA Synthetase of Leishmania donovani: A HOUSEKEEPING PROTEIN TRANSLATION ENZYME AND A MIMIC OF HOST CHEMOKINE. |
Q33569775 | Type I IFN suppresses Cxcr2 driven neutrophil recruitment into the sensory ganglia during viral infection |
Q37241332 | Type I IFNs mediate development of postinfluenza bacterial pneumonia in mice |
Q35224820 | Urinary CXCL1: a novel predictor of IgA nephropathy progression |
Q36907771 | Urinary chemokines as noninvasive predictors of ulcerative interstitial cystitis |
Q54276966 | VEGFR-2, CXCR-2 and PAR-1 germline polymorphisms as predictors of survival in pancreatic carcinoma. |
Q40268393 | Vascular microarchitecture of murine colitis-associated lymphoid angiogenesis |
Q37368134 | Villitis of unknown etiology is associated with a distinct pattern of chemokine up-regulation in the feto-maternal and placental compartments: implications for conjoint maternal allograft rejection and maternal anti-fetal graft-versus-host disease |
Q33933260 | Viral exploitation and subversion of the immune system through chemokine mimicry |
Q30369987 | Water-soluble egg membrane enhances the immunoactivating properties of an Aloe vera-based extract of Nerium oleander leaves. |
Q40027054 | hGPR87 contributes to viability of human tumor cells |
Search more.